Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

Revenues for METROPOLIS are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 1.161000
forwardPE 37.133354
debtToEquity 13.916000
earningsGrowth 0.122000
revenueGrowth 0.227000
grossMargins 0.772700
operatingMargins 0.176650
trailingEps 30.470000
forwardEps 48.834800

The current ratio for METROPOLIS is 1.161, indicating that the company can service its short-term debt using available cash and assets. This suggests METROPOLIS has strong liquidity, with more than enough resources to meet its immediate financial commitments.
METROPOLIS's low Debt-to-Equity ratio indicates the company is not over-leveraged. By limiting its dependence on debt, METROPOLIS reduces its financial risk and demonstrates a strong capital structure, making it a more stable investment option for those wary of excessive borrowing.
METROPOLIS's positive earnings and revenue growth reflect a strong outlook for the company's business expansion. The company is expected to continue growing, with increasing profitability and sales driving further growth in the near future.
METROPOLIS's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting METROPOLIS to generate stronger earnings compared to the previous financial year.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

Over time, price projections for METROPOLIS have risen steadily, pointing to growing optimism among analysts about the company's future. This upward trend suggests a positive outlook for METROPOLIS's continued growth.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


Metropolis Healthcare Limited has been receiving a buy bias from analysts, signaling strong confidence in the stock's future performance. This positive outlook might drive investors to view Metropolis Healthcare Limited as an attractive option for their portfolios, positioning the company as a stable and profitable investment choice.